{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:16:22Z","timestamp":1792696582405,"version":"4.5.0"},"reference-count":149,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":9934,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1984,11,12]]},"abstract":"<jats:p>Ketoconazole is a well\u2010tolerated oral antifungal agent with a broad spectrum of activity in vitro, but in vitro testing has not yet been correlated to in vivo results. In addition, many variables that can alter in vitro test results have been identified. The drug shows effectiveness in the treatment of paracoccidioidomycosis, chronic mucocutaneous candidiasis, oral thrush, coccidioidomycosis and histoplasmosis. It was recently approved for use in blastomycosis. It is not yet approved for use in dermatophyte infections, but a large body of literature exists supporting this application. Ketoconazole has several reported drug interactions, including lower bioavailability with cimetidine, accumulation of cyclosporin during concurrent therapy and a possible disulfiram\u2010like reaction with alcohol. It is highly protein bound to albumin and is extensively metabolized. Dosage adjustment is not required in renal failure. The main side effects are gastrointestinal and occur in 5\u201310% of the patients. Rare side effects include gynecomastia and hepatotoxicity. The latter is reported to occur in 1 of 12,000 patients. Ketoconazole impairs testosterone synthesis, and therefore it is recommended that administration more than once daily be avoided in men. The usual dosage is 200\u2013400 mg administered once daily. Few comparative or controlled studies have been published thus far. How it compares to amphotericin B is not known. The optimum dosage and the optimum duration of therapy are not established.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1984.tb03398.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T20:20:25Z","timestamp":1450297225000},"page":"343-373","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Ketoconazole; Mechanism of Action, Spectrum of Activity, Pharmacokinetics, Drug Interactions, Adverse Reactions and Therapeutic Use"],"prefix":"10.1002","volume":"4","author":[{"given":"Jeanne Hawkins","family":"Van Tyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/clinids\/2.4.674","article-title":"An evaluation of two years of clinical experience with ketoconazole","volume":"2","author":"Symoens J","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/jm00194a023","article-title":"Antimycotic imidazoles. 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad\u2010spectrum antifungal agent","volume":"22","author":"Heeres J","year":"1979","journal-title":"J Med Chem"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/AAC.19.1.110","article-title":"Liquid chromatographic assay of ketoconazole","volume":"19","author":"Andrews FA","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_5_2","first-page":"849","article-title":"Inhibition of ergosterol synthesis in Candida albicans by ketoconazole","volume":"87","author":"VandenBossche H","year":"1979","journal-title":"Arch Int Physiol Biochem"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/AAC.17.6.922","article-title":"In vitro and in vivo effects of the anti\u2010mycotic drug ketoconazole on sterol synthesis","volume":"17","author":"VandenBossche H","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/clinids\/2.4.520","article-title":"Mechanism of action of antifungal drugs with special reference to the imidazole derivatives","volume":"2","author":"Borgers M.","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archderm.1980.01640340047014","article-title":"Ketoconazole treatment of chronic mucocutaneous candidiasis","volume":"116","author":"Graybill JR.","year":"1980","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/AAC.21.6.919","article-title":"Effect of ketoconazole on isolated mitochondria from Candida albicans","volume":"21","author":"Shigematsu ML","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jac\/6.1.97","article-title":"The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole","volume":"6","author":"Odds RC","year":"1980","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/pgmj.55.647.657","article-title":"Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs","volume":"55","author":"Borelli D","year":"1979","journal-title":"Postgrad Med J"},{"issue":"1","key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0002-9343(83)90512-0","article-title":"Laboratory and clinical assessment of ketoconazole in deep\u2010seated mycoses","volume":"74","author":"Drouhet E","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_13_2","article-title":"Ketoconazole levels in the serum and CSF: minimal inhibitory concentrations to clinical isolates of fungi. Clin Res Rep R41400\/48","author":"Levine HB","year":"1980","journal-title":"Janssen Pharmaceutica"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.23.1.105","article-title":"Effects of pH on the activity of ketoconazole against Candida albicans","volume":"23","author":"Minagawa H","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.22.5.917","article-title":"Activity of ketoconazole and its deacyl derivative against Plasmodium falciparum and Candida isolates","volume":"22","author":"Pfaller MA","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/AAC.21.6.912","article-title":"Primary site of action of ketoconazole on Candida albicans","volume":"21","author":"Uno J","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0002-9343(83)90509-0","article-title":"Ketoconazole in the treatment of fungal infections","volume":"74","author":"Hay RJ.","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/clinids\/2.4.656","article-title":"Therapy of disseminated or pulmonary coccidioidomycosis with ketoconazole","volume":"2","author":"Brass C","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-95-4-446","article-title":"Progressive disseminated histoplasmosis: favorable response to ketoconazole","volume":"95","author":"Hawkins SS","year":"1981","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/clinids\/2.4.633","article-title":"Ketoconazole: a new drug for the treatment of paracoccidioidomycosis","volume":"2","author":"Restrepo AM","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7326\/0003-4819-93-6-921","article-title":"Ketoconazole: a major innovation for treatment of fungal disease","volume":"93","author":"Graybill JR","year":"1980","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1128\/AAC.15.6.763","article-title":"Variability of agar dilution\u2010replicator method of yeast susceptibility testing","volume":"15","author":"Brass C","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_23_2","first-page":"495","article-title":"Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicans","volume":"37","author":"Beggs WH.","year":"1982","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9343(83)90508-9","article-title":"The antifungal activity of ketoconazole","volume":"74","author":"VanCutsem J.","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/clinids\/2.4.661","article-title":"Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients","volume":"2","author":"Graybill JR","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/infdis\/138.5.681","article-title":"In vitro studies of amphotericin B in combination with the imidazole antifungal compounds clotrimazole and miconazole","volume":"138","author":"Cosgrove RF","year":"1978","journal-title":"J Infect Dis"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(76)90774-1","article-title":"Antagonism between miconazole and amphotericin B","volume":"2","author":"Schacter LP","year":"1976","journal-title":"Lancet"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/AAC.20.5.688","article-title":"Susceptibility of zymocetes to amphotericin B, miconazole, and ketoconazole","volume":"20","author":"Eng RH.","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_29_2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1128\/AAC.21.2.355","article-title":"Combined activity of ketoconazole and 5\u2010flucytosine on potentially pathogenic yeasts","volume":"21","author":"Beggs WH","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(83)70030-7","article-title":"Treatment of chromomycosis with ketoconazole and 5\u2010flucytosine","volume":"8","author":"Silber JG","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/pgmj.55.647.687","article-title":"Promotion of pseudomycelial formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole","volume":"55","author":"Borgers M","year":"1979","journal-title":"Postgrad Med J"},{"key":"e_1_2_1_32_2","first-page":"771","article-title":"Ketoconazole resistance (letter)","volume":"2","author":"Odds FC.","year":"1982","journal-title":"Lancet"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(82)91915-8","article-title":"Ketoconazole and the liver","volume":"1","author":"Horsburgh CR","year":"1982","journal-title":"Lancet"},{"issue":"1","key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(83)90511-9","article-title":"Long\u2010term therapy of CMC with ketoconazole: experience with twenty\u2010one patients","volume":"74","author":"Horsburgh CR","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_35_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(82)91051-0","article-title":"Resistance to ketoconazole","volume":"2","author":"Levine HB.","year":"1982","journal-title":"Lancet"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0140-6736(83)91809-3","article-title":"Modified response to ketoconazole of Candida albicans from a treatment failure","volume":"1","author":"Warnock DW","year":"1983","journal-title":"Lancet"},{"key":"e_1_2_1_37_2","first-page":"4","article-title":"Treatment of chronic mucocutaneous candidosis with ketoconazole: a study of 12 cases","volume":"2","author":"Hay RJ","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-98-1-13","article-title":"Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in fifty\u2010two patients","volume":"98","author":"Dismukes WE","year":"1983","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_39_2","first-page":"647","volume-title":"Manual of clinical microbiology","author":"Shadomy S","year":"1980"},{"key":"e_1_2_1_40_2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/132.4.407","article-title":"Miconazole in coccidioiodmycosis. I. Assays of activity in mice and in vitro","volume":"132","author":"Levine HB","year":"1975","journal-title":"J Infect Dis"},{"key":"e_1_2_1_41_2","article-title":"Plasma levels of R41400 in man, determined by bioassay after treatment with the water\u2010insoluble free base in capsules and with the dihydrochloride salt in aqueous solution. Clin Res Rep R41400\/1","author":"VanCutsem J","year":"1977","journal-title":"Janssen Pharmaceutica"},{"key":"e_1_2_1_42_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/AAC.14.3.509","article-title":"Quantitation of imidazoles by agar\u2010disk diffusion","volume":"14","author":"Grendahl JC","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_43_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1128\/AAC.20.1.59","article-title":"Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid","volume":"20","author":"Jorgensen JH","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_44_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0378-4347(00)84319-4","article-title":"Determination of the antifungal agent, ketoconazole, in human plasma by HPLC","volume":"221","author":"Alton KB.","year":"1980","journal-title":"J Chromatogr"},{"key":"e_1_2_1_45_2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0378-4347(00)80405-3","article-title":"Measurement of ketoconazole, a new antifungal agent, by high\u2010performance liquid chromatography","volume":"227","author":"Swezey SF","year":"1982","journal-title":"J Chromatogr"},{"key":"e_1_2_1_46_2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(82)91494-5","article-title":"Ketoconazole","volume":"2","author":"Daneshmend TK.","year":"1982","journal-title":"Lancet"},{"key":"e_1_2_1_47_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jac\/8.4.299","article-title":"Pharmacokinetics of ketoconazole in normal subjects","volume":"8","author":"Daneshmend TK","year":"1981","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_48_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-97-2-284_3","article-title":"Ketoconazole effects","volume":"97","author":"Stevens DA","year":"1982","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_49_2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jac\/11.6.598-a","article-title":"Ketoconazole absorption (letter)","volume":"11","author":"Davey PG.","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_50_2","article-title":"The bioavailability of ketoconazole in healthy male volunteers after oral administration of the drug at three dose levels and in two dosage forms. Clin Res Rep R41400\/26","author":"Heykants J","year":"1980","journal-title":"Janssen Pharmaceutica"},{"key":"e_1_2_1_51_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/AAC.21.1.151","article-title":"Disposition of ketoconazole, an oral antifungal, in humans","volume":"21","author":"Brass C","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_52_2","unstructured":"SutherlandCH MurphyJE SchlefiferNH.The effects of two gastric acidifying agents on the pharmacokinetics of ketoconazole. 18th Annual Midyear Clinical Meeting of the American Society of Hospital Pharmacists. Atlanta Georgia.Dec. 48 1983 p141."},{"key":"e_1_2_1_53_2","first-page":"1334","article-title":"Effect of pH on disintegration and dissolution of ketoconazole tablets","volume":"40","author":"Carlson JA","year":"1983","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_54_2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/AAC.21.5.730","article-title":"Impairing effect of food on ketoconazole absorption","volume":"21","author":"Mannisto PT","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_55_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198223010-00001","article-title":"Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections","volume":"23","author":"Heel RC","year":"1982","journal-title":"Drugs"},{"key":"e_1_2_1_56_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jac\/6.5.681","article-title":"CSF concentrations of ketoconazole","volume":"6","author":"Fibbe WE","year":"1980","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_57_2","volume-title":"Ketoconazole in the management of fungal disease","author":"Heel RC.","year":"1982"},{"key":"e_1_2_1_58_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198001173020304","article-title":"Strategies in the treatment of systemic fungal infections","volume":"302","author":"Medoff G","year":"1980","journal-title":"N Engl J Med"},{"key":"e_1_2_1_59_2","first-page":"26","article-title":"Inhibition and induction of microsomal enzymes in rat","volume":"251","author":"Neimegeers CJ","year":"1981","journal-title":"A comparative study of four anti-mycotics: miconazole, econazole, clotrimazole and ketoconazole, Arch Int Pharmacodyn Ther"},{"key":"e_1_2_1_60_2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(82)91545-8","article-title":"Ketoconazole\u2010cyclosporin interaction","volume":"2","author":"Daneshmend TK.","year":"1982","journal-title":"Lancet"},{"key":"e_1_2_1_61_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/12.2.185","article-title":"Multiple\u2010dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man","volume":"12","author":"Daneshmend TK","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_62_2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.7326\/0003-4819-99-3-334","article-title":"Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis","volume":"99","author":"Kerr CM","year":"1983","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_63_2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0140-6736(83)90534-2","article-title":"Ketoconazole and fungal CAPD peritonitis","volume":"2","author":"Chapman JR","year":"1983","journal-title":"Lancet"},{"key":"e_1_2_1_64_2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/jac\/6.4.552","article-title":"The influence of gastric acidity on the bio\u2010availability of ketoconazole","volume":"6","author":"VanderMeer JW","year":"1980","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"e_1_2_1_65_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0002-9343(83)90515-6","article-title":"Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis","volume":"74","author":"Stevens DA","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_66_2","first-page":"261","article-title":"Ketoconazole therapy of Candida esophagitis \u2014 a prospective study of 12 cases","volume":"79","author":"Fazio RA","year":"1983","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_67_2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(82)90851-0","article-title":"Ketoconazolecyclosporin metabolism and renal transplantation","volume":"2","author":"Ferguson RM","year":"1982","journal-title":"Lancet"},{"key":"e_1_2_1_68_2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(82)91231-4","article-title":"Ketoconazole and cyclosporin A","volume":"2","author":"Dieperink H","year":"1982","journal-title":"Lancet"},{"key":"e_1_2_1_69_2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(82)91544-6","article-title":"Ketoconazole\u2010cyclosporin interaction (letter)","volume":"2","author":"Morgenstern GR","year":"1982","journal-title":"Lancet"},{"key":"e_1_2_1_70_2","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(82)91366-6","article-title":"Ketoconazole, cyclosporin, and the kidney","volume":"2","author":"Cunningham MC","year":"1982","journal-title":"Lancet"},{"key":"e_1_2_1_71_2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.7326\/0003-4819-98-2-160","article-title":"High\u2010dose ketoconazole for treatment of fungal infections of the central nervous system","volume":"98","author":"Craven PC","year":"1983","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_72_2","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/bmj.287.6406.1673","article-title":"Anaphylactic reactions to ketoconazole","volume":"287","author":"VanDijke CPH","year":"1983","journal-title":"Br Med J"},{"key":"e_1_2_1_73_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archderm.1983.01650260005004","article-title":"Ketoconazole and exfoliative erythroderma","volume":"119","author":"Rand R","year":"1983","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_74_2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-93-6-791","article-title":"Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical study","volume":"93","author":"Petersen EA","year":"1980","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_75_2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/bmj.283.6295.825","article-title":"Toxic hepatitis during ketoconazole treatment","volume":"283","author":"Heiberg JK","year":"1981","journal-title":"Br Med J"},{"key":"e_1_2_1_76_2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/bmj.283.6298.1058-d","article-title":"Hepatitis and ketoconazole therapy","volume":"282","author":"Firebrace DAJ.","year":"1981","journal-title":"Br Med J"},{"key":"e_1_2_1_77_2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0190-9622(82)80375-7","article-title":"Ketoconazole and the liver (letter)","volume":"6","author":"Strauss JS.","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_1_78_2","first-page":"482","article-title":"Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis","volume":"29","author":"Tkach JR.","year":"1982","journal-title":"Cutis"},{"key":"e_1_2_1_79_2","first-page":"1058","article-title":"Hepatitis and ketoconazole therapy","volume":"283","author":"MacNair AL","year":"1981","journal-title":"Br Med J"},{"key":"e_1_2_1_80_2","first-page":"11","article-title":"Hepatotoxic potential of ketoconazole under investigation","volume":"12","author":"Anonymous.","year":"1982","journal-title":"FDA Drug Bull"},{"issue":"1","key":"e_1_2_1_81_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9343(83)90519-3","article-title":"Hepatic reactions during ketoconazole treatment","volume":"74","author":"Janssen PA","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_82_2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.19.6.1073","article-title":"Gynecomastia with ketoconazole","volume":"19","author":"DeFelice R","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_83_2","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/archinte.1982.00340250097015","article-title":"Ketoconazole blocks testosterone synthesis","volume":"142","author":"Pont A","year":"1982","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_84_2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(82)90021-6","article-title":"Ketoconazole\u2010induced drop in serum and saliva testosterone","volume":"2","author":"Schurmeyer T","year":"1982","journal-title":"Lancet"},{"key":"e_1_2_1_85_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/AAC.23.2.207","article-title":"Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport proteins","volume":"23","author":"Grosso DS","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_86_2","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1136\/bmj.287.6407.1766","article-title":"Combined treatment with ketoconazole and leuteinising hormone analogue: a novel approach to resistant progressive prostatic cancer","volume":"287","author":"Allen JM","year":"1983","journal-title":"Br Med J"},{"key":"e_1_2_1_87_2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-5347(17)51007-1","article-title":"Ketoconazole; a novel and rapid treatment for advanced prostatic cancer","volume":"130","author":"Trachtenberg J","year":"1983","journal-title":"J Urol"},{"key":"e_1_2_1_88_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-97-3-370","article-title":"Ketoconazole blocks adrenal steroid synthesis","volume":"97","author":"Pont A","year":"1982","journal-title":"Ann Intern Med"},{"issue":"1","key":"e_1_2_1_89_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0002-9343(83)90513-2","article-title":"Post\u2010therapy status of paracoccidioidomycosis treated with ketoconazole","volume":"74","author":"Restrepo AM","year":"1983","journal-title":"Am J Med"},{"issue":"1","key":"e_1_2_1_90_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0002-9343(83)90513-2","article-title":"Treatment of paracoccidioidomycosis with ketoconazole: a three\u2010year experience","volume":"74","author":"Restrepo AM","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_91_2","first-page":"340","article-title":"Paracoccidioidomycosis in the immunosuppressed host: report of a case and a review of the literature","volume":"129","author":"Sugar AM","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_92_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-4362.1980.tb03740.x","article-title":"Treatment of paracoccidioidomycosis, candidosis, chromomycosis, lobomycosis, and mycetoma with ketoconazole","volume":"19","author":"Cuce' LC","year":"1980","journal-title":"Int J Dermatol"},{"key":"e_1_2_1_93_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/clinids\/2.4.599","article-title":"Treatment of chronic mucocutaneous candidosis with ketoconazole: preliminary results of a controlled double\u2010blind study","volume":"2","author":"Kirkpatrick C","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_94_2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-3476(80)80036-9","article-title":"Successful treatment of chronic mucocutaneous candidiasis with ketoconazole","volume":"97","author":"Rosenblatt HM","year":"1980","journal-title":"J Pediatr"},{"key":"e_1_2_1_95_2","first-page":"963","volume-title":"Current chemotherapy and infectious diseases","author":"Rosenblatt HM","year":"1980"},{"key":"e_1_2_1_96_2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/clinids\/2.4.606","article-title":"Chronic mucocutaneous candidosis and other superficial and systemic mycoses successfully treated with ketoconazole","volume":"2","author":"Drouhet E","year":"1980","journal-title":"Rev Infect Dis"},{"issue":"1","key":"e_1_2_1_97_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9343(83)90510-7","article-title":"Therapy of chronic mucocutaneous candidiasis","volume":"74","author":"Rosenblatt HM","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_98_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2230.1982.tb02403.x","article-title":"The treatment of patients with chronic mucocutaneous candidiasis and Candida onychomycosis with ketoconazole","volume":"7","author":"Hay RJ","year":"1982","journal-title":"Clin Exp Dermatol"},{"key":"e_1_2_1_99_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2340\/00015555628789","article-title":"Ketoconazole in a case of chronic mucocutaneous candidiasis","volume":"62","author":"Zachariare H","year":"1981","journal-title":"Acata Derm Venereol (Stockh)"},{"key":"e_1_2_1_100_2","article-title":"The treatment of oral thrush with ketoconazole in patients with malignancies","author":"Ferrant A","year":"1978","journal-title":"Janssen Pharmceutica"},{"key":"e_1_2_1_101_2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0140-6736(82)91874-8","article-title":"Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients","volume":"1","author":"Hann IM","year":"1982","journal-title":"Lancet"},{"key":"e_1_2_1_102_2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1439-0507.1982.tb02729.x","article-title":"An evaluation of two years experience with ketoconazole","volume":"25","author":"Torok I","year":"1982","journal-title":"Mykosen"},{"issue":"1","key":"e_1_2_1_103_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0002-9343(83)90517-X","article-title":"Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole","volume":"74","author":"Slama TG.","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_104_2","unstructured":"ReinarzJA MaderJT MasekJL.Ketoconazole therapy for disseminated histoplasmosis. 20th Interscience Conference on Antimicrobial Agents and Chemotherapy New Orleans Louisiana.September 1980."},{"key":"e_1_2_1_105_2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/clinids\/2.4.643","article-title":"Ketoconazole in the treatment of paracoccidioidomycosis and histoplasmosis","volume":"2","author":"Negroni R","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_106_2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1439-0507.1982.tb02752.x","article-title":"Superficial mycoses: ketoconazole treatment","volume":"25","author":"Grigoriu A","year":"1982","journal-title":"Mykosen"},{"key":"e_1_2_1_107_2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.7326\/0003-4819-93-6-838","article-title":"Relapse of Candida parapsilosis endocarditis after long\u2010term suppression with flucytosine: retreatment with valve replacement and ketoconazole","volume":"93","author":"Samelson LE","year":"1980","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_108_2","first-page":"91","volume-title":"Boerhaave Cursus Committee for Postgraduate Medical Education. Diagnosis and therapy of systemic mycoses","author":"Symoens J","year":"1981"},{"key":"e_1_2_1_109_2","article-title":"Oral ketoconazole treatment in 47 patients with systemic candidosis","author":"Barbee R","year":"1980","journal-title":"Janssen Pharmaceutica"},{"key":"e_1_2_1_110_2","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/archinte.1982.00340230182031","article-title":"Apparent ketoconazole failure in candidal cholecystitis","volume":"142","author":"Brooks BJ","year":"1982","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_111_2","first-page":"698","article-title":"Postoperative peritonitis due to Saccharomyces cerevisiae treated with ketoconazole","volume":"16","author":"Canafax DM","year":"1982","journal-title":"Drug Intell Clin Pharm"},{"key":"e_1_2_1_112_2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/bmj.285.6346.923","article-title":"Fungal arthritis simulating juvenile rheumatoid arthritis","volume":"285","author":"Haapasaari J","year":"1982","journal-title":"Br Med J"},{"key":"e_1_2_1_113_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/clinids\/4.1.78","article-title":"Septic arthritis due to Candida species in patients with cancer","volume":"4","author":"Fainstein V","year":"1982","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_114_2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0002-9394(14)78302-3","article-title":"Oral ketoconazole therapy for keratomycosis","volume":"95","author":"Ishibashi Y.","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_1_115_2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/infdis\/147.6.1060","article-title":"Ketoconazole and candidiasis: a controlled study","volume":"147","author":"Hughes WA","year":"1983","journal-title":"J Infect Dis"},{"key":"e_1_2_1_116_2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7326\/0003-4819-96-4-440","article-title":"Ketoconazole for the treatment of chronic pulmonary coccidioidomycosis","volume":"96","author":"Ross JB","year":"1982","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_117_2","first-page":"171","article-title":"Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens","volume":"126","author":"Graybill JR","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_118_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-97-2-284_3","article-title":"Ketoconazole effects (letter)","volume":"97","author":"Stevens DA.","year":"1982","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_119_2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7326\/0003-4819-96-4-436","article-title":"Ketoconazole for treatment of disseminated coccidioidomycosis","volume":"96","author":"Catanzaro A","year":"1982","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_120_2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/clinids\/2.4.651","article-title":"Therapeutic evaluation of ketoconazole in patients with coccidioidomycosis","volume":"2","author":"Welsh O","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_121_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0002-9343(82)90480-6","article-title":"Ketoconazole treatment of nonprimary coccidioidomycosis","volume":"72","author":"DeFelice R","year":"1982","journal-title":"Am J Med"},{"issue":"1","key":"e_1_2_1_122_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0002-9343(83)90515-6","article-title":"Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis","volume":"74","author":"Stevens DA","year":"1983","journal-title":"Am J Med"},{"issue":"1","key":"e_1_2_1_123_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0002-9343(83)90516-8","article-title":"Treatment of coccidioidomycosis with ketoconazole; an evaluation utilizing a new scoring system","volume":"74","author":"Catanzaro A","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_124_2","first-page":"511","article-title":"The systemic treatment of recurrent vaginal candidosis \u2014 an evaluation of oral ketoconazole","volume":"31","author":"Balsdon MJ","year":"1982","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_125_2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/clinids\/2.4.620","article-title":"Ketoconazole in vulvovaginal candidosis","volume":"2","author":"Fregoso\u2010Duenas F.","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_126_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9378(83)90953-5","article-title":"Treatment of vaginal candidiasis with ketoconazole (letter)","volume":"146","author":"Tkach JR","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_127_2","first-page":"746","article-title":"Chromoblastomycosis treatment with ketoconazole","volume":"30","author":"McBurney EI.","year":"1982","journal-title":"Cutis"},{"key":"e_1_2_1_128_2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archderm.1981.01650050067028","article-title":"Chromohyphomycosis: treatment with ketoconazole","volume":"117","author":"South DA","year":"1981","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_129_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-5347(17)51922-9","article-title":"Ketoconazole therapy for fungal urinary tract infections","volume":"129","author":"Graybill JR","year":"1983","journal-title":"J Urol"},{"key":"e_1_2_1_130_2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0022-5347(17)52111-4","article-title":"The use of ketoconazole to treat systemic blastomycosis presenting as acute epidymitis","volume":"129","author":"Short KL","year":"1983","journal-title":"J Urol"},{"key":"e_1_2_1_131_2","first-page":"268","article-title":"The successful treatment of mycotic infections in immunosuppressed renal transplant recipients with ketoconazole","volume":"20","author":"Zazgornik J","year":"1982","journal-title":"Int J Cin Pharmacol Ther Toxicol"},{"key":"e_1_2_1_132_2","first-page":"47","volume-title":"Principles and practice of infectious diseases","author":"Fields BT.","year":"1979"},{"key":"e_1_2_1_133_2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7326\/0003-4819-98-2-260_2","article-title":"Ketoconazole and blastomycotic osteomyelitis","volume":"98","author":"Clafin K","year":"1983","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_134_2","first-page":"75","article-title":"Human blastomycosis after a dog bite","volume":"33","author":"Gnann JW","year":"1983","journal-title":"Curr Ther Res Clin Exp"},{"key":"e_1_2_1_135_2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/clinids\/2.4.596","article-title":"The activity of ketoconazole in the treatment of onychomycosis","volume":"2","author":"Galimberti R","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_136_2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2230.1982.tb02485.x","article-title":"Treatment of chronic dermatophyte infections. The use of ketoconazole in griseofulvin treatment failures","volume":"7","author":"Hay RJ","year":"1982","journal-title":"Clin Exp Dermatol"},{"key":"e_1_2_1_137_2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0190-9622(82)70015-5","article-title":"Ketoconazole in griseofulvin\u2010resistant dermatophytosis","volume":"6","author":"Robertson MH","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_1_138_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archderm.1981.01650030007007","article-title":"Oral ketoconazole. An effective and safe treatment for dermatophpytosis","volume":"117","author":"Jones HE","year":"1981","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_139_2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.1982.tb00530.x","article-title":"Pityrosporon folliculitis and ketoconazole","volume":"107","author":"Ford GP","year":"1982","journal-title":"Br J Dermatol"},{"key":"e_1_2_1_140_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.1982.01650180004002","article-title":"Improvement of psoriasis of the scalp with ketoconazole (letter)","volume":"118","author":"Rosenberg EW","year":"1982","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_141_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0190-9622(82)80198-9","article-title":"The successful treatment of pityriasis versicolor by systemic ketoconazole","volume":"6","author":"Urcuyo F","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_1_142_2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/clinids\/2.4.592","article-title":"Treatment of pityriasis versicolor with ketoconazole","volume":"2","author":"Borelli D.","year":"1980","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_143_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2230.1981.tb02367.x","article-title":"Systemic treatment of tinea versicolor with ketoconazole in 44 patients","volume":"6","author":"Jolliffe DS","year":"1981","journal-title":"Clin Exp Dermatol"},{"key":"e_1_2_1_144_2","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1001\/jama.1982.03320490047035","article-title":"Failure of ketoconazole in cryptococcal meningitis","volume":"247","author":"Perfect JR","year":"1982","journal-title":"JAMA"},{"key":"e_1_2_1_145_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.22.1.43","article-title":"Pharmacokinetics of ketoconazole in patients with neoplastic diseases","volume":"22","author":"Maksymiuk AW","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_146_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0002-9343(83)90518-1","article-title":"Treatment of mycoses in cancer patients","volume":"74","author":"Meunier\u2010Carpenter F.","year":"1983","journal-title":"Am J Med"},{"key":"e_1_2_1_147_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/AAC.20.5.660","article-title":"Ketoconazole, amphotericin B, and amphotericin B methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil function","volume":"20","author":"Marmer DJ","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_148_2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-4362.1982.tb03163.x","article-title":"Oral ketoconazole in the treatment of leishmaniasis","volume":"21","author":"Urcuyo FG","year":"1982","journal-title":"Int Soc Tropical Dermatol"},{"key":"e_1_2_1_149_2","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/infdis\/147.6.1064","article-title":"Treatment of fungal infections in the bones and joints with ketoconazole","volume":"147","author":"Horsburgh CR","year":"1983","journal-title":"J Infect Dis"},{"key":"e_1_2_1_150_2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/bmj.285.6346.923","article-title":"Fungal arthritis simulating juvenile rheumatoid arthritis","volume":"285","author":"Haapasaari J","year":"1982","journal-title":"Br Med J"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1984.tb03398.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1984.tb03398.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1984.tb03398.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:49:41Z","timestamp":1761061781000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1984.tb03398.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,11,12]]},"references-count":149,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1984,11,12]]}},"alternative-id":["10.1002\/j.1875-9114.1984.tb03398.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1984.tb03398.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,11,12]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}